Skip to content
Holistic Vive

Holistic Vive

Health is the key to success and happiness

Primary Menu Holistic Vive

Holistic Vive

  • Blood Clotting Healthcare
  • Kidney Healthcare
  • Liver Healthcare
  • Liver Cancer Healthcare
  • Brain Healthcare and Neurology
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • Reporter

Reporter

AI predicts blood clot risk in hospitalized children: VUMC study | VUMC Reporter
  • Blood Clotting Healthcare

AI predicts blood clot risk in hospitalized children: VUMC study | VUMC Reporter

admin January 27, 2024 0

  by Bill Snyder An artificial intelligence (AI) tool developed at Vanderbilt University Medical Center accurately identified pediatric patients at...

Read MoreRead more about AI predicts blood clot risk in hospitalized children: VUMC study | VUMC Reporter

Recent Posts

  • Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • AI in Liver Care Needs Vigilance and Tailoring to Population
  • Kidney Dialysis Equipment Market, In-Depth Analysis
  • KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

Archives

Categories

  • Blood Clotting Healthcare
  • Brain Healthcare and Neurology
  • Kidney Healthcare
  • Liver Cancer Healthcare
  • Liver Healthcare

Visit Us

Advancing Business Horizons

You may have missed

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News
  • Liver Cancer Healthcare

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0
AI in Liver Care Needs Vigilance and Tailoring to Population
  • Liver Healthcare

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0
Kidney Dialysis Equipment Market, In-Depth Analysis
  • Kidney Healthcare

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0
KHSC expands liver cancer treatment with cutting-edge Y90 therapy
  • Liver Cancer Healthcare

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0
GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)
  • Liver Healthcare

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0
Copyright © All rights reserved. | CoverNews by AF themes.